Home

JEREMY MINDICH

CIK 1431207 · last filed 2019-05-23

JEREMY MINDICH is a corporate insider who has filed 21 SEC Form 4 insider transactions across 5 companies since 2008. The most recent filing shows the insider sold $12.7M of ITRI on May 23, 2019. Across all open-market trades the lifetime net is −$23.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $602.4M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$602.44M

Companies

5

Total Filings

21

Lifetime Open-Market Net

-$22.97M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ITRI 10%+ Owner 4,005,794 $83.93 $336.21M -$13.75M 7 2019-05-23
Acorda Therapeutics, Inc. (ACOR) Delisted 10%+ Owner 40,551 $0.66 $26.8K -$19.93M 3 2019-01-22
Barzel Industries Inc. (TONSW) Delisted 10%+ Owner 2,559,673 — — $7.40M 3 2009-01-06
SOURCE INTERLINK COMPANIES INC (SORC) Delisted 10%+ Owner 5,282,276 — — -$791.3K 3 2008-07-02
CENT 10%+ Owner 6,194,326 $42.98 $266.23M $4.10M 3 2008-05-09

Recent Filings

21 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2019-05-23 ITRI Sell (S) −220,344 -$12.66M EDGAR
2019-05-01 ITRI Sell (S) −167,452 -$8.89M EDGAR
2019-03-27 ITRI Sell (S) −194,736 -$9.18M EDGAR
2019-01-22 Acorda Therapeutics, Inc. (ACOR) Delisted Sell (S) −557,432 -$9.30M EDGAR
2018-11-13 ITRI Sell (S) −306,776 -$16.46M EDGAR
2018-10-09 Acorda Therapeutics, Inc. (ACOR) Delisted Sell (S) −615,432 -$10.63M EDGAR
2018-10-03 Acorda Therapeutics, Inc. (ACOR) Delisted Other (J) −563,616 $0 EDGAR
2018-05-29 ITRI Buy (P) +80,000 $4.75M EDGAR
2016-03-11 ITRI Buy (P) +213,068 $8.96M EDGAR
2016-02-24 ITRI Buy (P) +492,056 $19.72M EDGAR
Showing 1–10 of 21
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.